Granite Point Capital Management’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-65,729
| Closed | -$379K | – | 3 |
|
|
2023
Q1 | $379K | Buy |
65,729
+20,729
| +46% | +$119K | 0.53% | 23 |
|
|
2022
Q4 | $402K | Hold |
45,000
| – | – | 0.26% | 50 |
|
|
2022
Q3 | $640K | Sell |
45,000
-152,898
| -77% | -$2.17M | 0.26% | 48 |
|
|
2022
Q2 | $2.89M | Hold |
197,898
| – | – | 0.74% | 9 |
|
|
2022
Q1 | $3.95M | Hold |
197,898
| – | – | 0.82% | 15 |
|
|
2021
Q4 | $3.46M | Hold |
197,898
| – | – | 0.59% | 27 |
|
|
2021
Q3 | $1.55M | Sell |
197,898
-37,850
| -16% | -$297K | 0.12% | 63 |
|
|
2021
Q2 | $2.43M | Sell |
235,748
-4,252
| -2% | -$43.8K | 0.09% | 48 |
|
|
2021
Q1 | $3.14M | Buy |
+240,000
| New | +$3.14M | 0.12% | 37 |
|